The researchers found that WGS can streamline disease diagnosis and used it to discover unknown etiological variants in coding and non-coding genomic regions.
The Sydney Morning Herald reports that a study using ultrarapid genetic testing was able to diagnose about half the critically ill infants and children tested.
The company, headquartered in Rostock, Germany, reported €15.2 million ($16.4 million) in revenues for Q4, with growth driven by its pharmaceutical business.
Invitae will provide free genetic testing on a 53-gene panel and counseling to patients suspected of having an LSD to facilitate earlier diagnosis and appropriate treatment.
Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.
